Thus, transgenic inhibition of NF-κβ in astroglia improved the outcome measures of experimental glaucoma, including the inflammatory phenotype of glia, neuron (including both RGC axons and somas) counts, and PERG responses. Here, NFKB1 is linked to glaucoma.